December 4, 2008 – SYGNIS Pharma AG today announced that the USPTO published a Notice of Allowance for the patent application which protects the treatment of stroke patients with AX200 in the USA. SYGNIS exclusively licensed the respective global rights to this patent application.
The details can be read here.
No comments:
Post a Comment